Anticachectic regulator analysis reveals Perp-dependent antitumorigenic properties of 3-methyladenine in pancreatic cancer
Aneesha Dasgupta(University of North Carolina at Charlotte), Jason D. Doles(Universitat Pompeu Fabra), R. Schmitt(Institute for Musculoskeletal Health), Tara L. Hogenson(Mayo Clinic), Dong Seong Cho(Mayo Clinic in Arizona), William R. Bamlet(Mayo Clinic), Gina L. Razidlo(Mayo Clinic), Eugene W. Krueger, Alexandra M. Ducharme(Mayo Clinic in Arizona), Martín E. Fernández-Zapico(Mayo Clinic in Arizona), Lizhi Zhang(Dalian Maritime University), Paige C. Arneson‐Wissink(Mayo Clinic in Arizona)
Cited by 20
Related Papers
Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer
|Nature Genetics|2009|724
A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33
|Nature Genetics|2010|614
Association Between Inherited Germline Mutations in Cancer Predisposition Genes and Risk of Pancreatic Cancer
|JAMA|2018|580
Long-Term Survival After Pancreatoduodenectomy for Pancreatic Adenocarcinoma
|Annals of Surgery|2008|461
Diagnosis of IgG4-Related Tubulointerstitial Nephritis
|Journal of the American Society of Nephrology|2011|374